A Bioscaffold to Enhance the Fibrillogenesis in Healing Ligaments
Rui Liang,Tan D. Nguyen,Rayna Nola,Alejandro Almarza,Savio L. Woo
2002-01-01
Abstract:Introduction: The medial collateral ligament (MCL) of the knee is frequently injured. Studies have shown that it can heal with functional management, but the tissue organization, the collagen fibril diameters and the biomechanical properties remain inferior [1]. The fibrillogenesis-related extracellular matrix (ECM) molecules, including collagen type III, V and small leucine-rich proteoglycans (SLRPs), also have been shown to be up-regulated, which limit the formation of large collagen fibrils [2]. Recently, our research center has shown that porcine small intestinal submucosa (SIS), a biologically derived scaffold containing growth factors and chemotactic factors, could significantly improve the mechanical properties of healing MCLs with concomitant accumulation of collagen fibrils with larger diameters up to 26 weeks post-injury [3]. However, the underlying fibrillogenesis changes remain to be elucidated. Thus, the research question under study was whether the SIS could improve the fibrillogenesis in the healing ligaments in terms of morphology and the fibrillogenesis-related gene expressions at an early stage. The objective of this study was to determine the effects of SIS treatment on the organization of extracellular matrix, collagen fibril diameter as well as the gene expressions of collagen type I, V, III and SLRPs (decorin, biglycan, lumican and fibrimodulin) following a gap injury of the rabbit MCL at 6 weeks, at which time point, the gene expressions undergo large changes and enough healing tissue could be collected for analysis. Materials and Methods: Twenty skeletally mature, female New Zealand white rabbits were used. In all animals, a 6 mm gap was surgically created in the MCL of the right knee, while the MCL of the left knee served as a sham-operated control. The animals were equally divided into an SIS-treated group and a non-treated group. In the SIS-treated group, a single strip of SIS (200 μm thick) was sutured onto the gap, while no SIS was applied in the non-treated group. At 6 weeks postinjury, 2 animals in each group were sacrificed for Masson’s trichrome staining, while the remaining 8 animals in each group were used for gene expression analysis. From these rabbits, a piece of tissue about 1mm x 1mm x 4mm was taken from the center of the healing tissue of 4 rabbits in each group for the purpose of transmission electron microscopy (TEM) examination. Specifically, for TEM, the tissue was fixed, embedded in LR White embedding resin, thinly cut (0.1μm) and stained. SimplePCI software was used to measure the diameters of collagen fibrils. For the gene expression analysis, the total RNA was isolated using TRIZOL® solution. cDNA was synthesized using 1μg of total RNA. Finally, quantitative realtime PCR was utilized to quantify mRNA levels in a Lightcycler using SYBR Green fluorescent dye. The expression of the target genes was normalized to the mRNA level of GAPDH in the corresponding samples (set as 100%). A Kolmogorov-Smirnov test was used to compare the distributions of collagen fibril diameters between the groups. Other data were compared using a one-factor analysis-of-variance (ANOVA) and Bonferroni multiple comparison post-hoc test. Significance was set at p<0.05. Results: All gap injuries of the MCLs except 5 in the non-treated group healed with neoligamentous tissue that completely filled the gaps at 6 weeks post-injury. The SIS scaffold was not visible upon gross examination. The Masson’s trichrome staining showed that the SIS-treated group had an improved organization of the extracelluar matrix with more aligned collagen fibers and spindle-shaped healing cells oriented in the longitudinal direction than that in the non-treated ligaments, which were disorganized with no obvious orientation. The cross-sectional morphology of the collagen fibrils examined by TEM revealed that larger collagen fibrils appeared around the fibroblasts in the SIS-treated ligaments for which the diameter distribution ranged from 24 to 120 nm as compared to the uniform small fibrils in the non-treated ligaments (range from 26 to 87 nm, p<0.05) (Fig. 1). For the fibrillogenesis-related gene expressions, the mRNAs of collagen types I, III, V, biglycan and lumican were all significantly increased in the non-treated ligaments when compared with those in the sham group (117%, 233%, 112%, 93% and 114% over sham values, respectively, all p<0.05), while those for the decorin and fibromodulin were 60% and 66% lower than those for the sham group, respectively (p<0.05). After the SIS treatment, the mRNAs of collagen type I, III and fibrimodulin in the healing ligaments did not differ significantly from the non-treated ones and were still significantly higher or lower than those for the sham group (63% and 218% over sham values for Col I and III, 60% less than the sham for fibrimodulin, p <0.05). However, the mRNA levels of collagen type V, decorin, biglycan and lumican were down-regulated by 41%, 58%, 51% and 43% respectively, compared to those for the non-treated group (p<0.05). And these values did not differ from the sham significantly (p>0.05), except that the gene expression of decorin was 83% lower than that for the sham group (p < 0.05).